Gene · 8644
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of AKR1C3 attenuates sepsis-induced acute liver injury by blocking the TRAF6/NF-κB pathway and NLRP3 inflammasome activation. | Int Immunopharmacol | 2026 | 41270642 | PubTator, text mining | PubMed |
| Identification of Metabolites for the Novel 5α-Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing. | Drug Test Anal | 2026 | 41242714 | PubTator, text mining | PubMed |
| Exploring the potency of 6-bromo-3-methylquinoline analogues as prostaglandin F2α inhibitors. | Z Naturforsch C J Biosci | 2026 | 40967607 | PubTator, text mining | PubMed |
| Multiomics analysis uncovers subtype-specific mechanisms and biomarkers in idiopathic inflammatory myopathies. | Ann Rheum Dis | 2026 | 40935702 | PubTator, text mining | PubMed |
| Synergistic Efficacy of Gedatolisib and Darolutamide in Prostate Cancer to Overcome Resistance to Androgen-Targeted Therapy. | Int J Mol Sci | 2025 | 41778397 | PubTator, text mining | PubMed |
| KEAP1 mutations activate the NRF2 pathway to drive cell growth and migration, and attenuate drug response in thyroid cancer. | Front Oncol | 2025 | 41573641 | PubTator, text mining | PubMed |
| Prognostic Significance and Mechanistic Insights of Rutin-Related Ferroptosis Gene Signature in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2025 | 41458070 | PubTator, text mining | PubMed |
| Network pharmacology identifies AKR1C3 and KYNU as potential targets of Astragalus Membranaceus and Ephedra in pediatric obesity-associated asthma. | Sci Rep | 2025 | 41366037 | PubTator, text mining | PubMed |
Sex-specific association of prenatal exposure to halogenated persistent organic pollutants (Hal-POPs) with neonatal sex hormone levels and birth size: a birth cohort study using meconium as a biomonitoring matrix. | Environ Int | 2025 | 41317605 | PubTator, text mining | PubMed |
| Vitexin as a Potential Antidysmenorrheic Agent: Development of a ZIF-8-Based Immediate-Release System and Evaluation via In Vivo and In Silico Approaches. | Biomedicines | 2025 | 41301696 | PubTator, text mining | PubMed |
| Tirabrutinib-anthracycline interactions in the brain tumor microenvironment: a focus on metabolic inactivation and resistance. | Expert Opin Drug Metab Toxicol | 2025 | 41297046 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Ferroptosis-Related Genes in Parkinson's Disease. | Eur J Neurosci | 2025 | 41276944 | PubTator, text mining | PubMed |
| Qingre huazhuo tang regulates IgA nephropathy through immune checkpoints and ferroptosis. | J Tradit Complement Med | 2025 | 41169938 | PubTator, text mining | PubMed |
| Corrigendum to "The AKR1C3/AR-V7 Complex Maintains CRPC Tumour Growth by Repressing B4GALT1 Expression". | J Cell Mol Med | 2025 | 41108204 | PubTator, text mining | PubMed |
| A Dual CYP17A1/HDAC6 Inhibitor for Targeted Prostate Cancer Therapy. | FASEB J | 2025 | 41105425 | PubTator, text mining | PubMed |
| Rosmarinic acid induces ferroptosis in colon cancer: insights from AKR1C3/PTGS2 pathway and mitochondrial dysfunction. | 3 Biotech | 2025 | 41064160 | PubTator, text mining | PubMed |
| Integrated HS-SPME-GC/MS and RNA sequencing analysis reveals metabolic differences of flavor compounds of muscle tissues with different intramuscular fat contents from Tibetan sheep. | BMC Genomics | 2025 | 40999319 | PubTator, text mining | PubMed |
| An immunometabolism-related signature for renal clear cell carcinoma diagnosis and therapeutic target. | J Cell Commun Signal | 2025 | 40977852 | PubTator, text mining | PubMed |
| The Role of Air Pollution in the Pathogenesis of Atopic Dermatitis, With a Focus on Oxidative Stress. | Clin Transl Allergy | 2025 | 40955089 | PubTator, text mining | PubMed |
| Typhae Pollen active subfraction exerts antiangiogenic effect in benign prostatic hyperplasia via regulating the VEGF signaling pathway and arachidonic acid metabolism. | Phytomedicine | 2025 | 40934757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8644/papers?page=5